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Purpose: Retinitis pigmentosa (RP) is a genetically heterogeneous disorder characterized by progressive loss of vision.
The aim of this study was to identify the causative mutations in 272 Spanish families using a genotyping microarray.
Methods: 272 unrelated Spanish families, 107 with autosomal recessive RP (arRP) and 165 with sporadic RP (sRP), were
studied using the APEX genotyping microarray. The families were also classified by clinical criteria: 86 juveniles and
186 typical RP families. Haplotype and sequence analysis were performed to identify the second mutated allele.
Results: At least one-gene variant was found in 14% and 16% of the juvenile and typical RP groups respectively. Further
study identified four new mutations, providing both causative changes in 11% of the families. Retinol Dehydrogenase 12
(RDH12) was the most frequently mutated gene in the juvenile RP group, and Usher Syndrome 2A (USH2A) and Ceramide
Kinase-Like (CERKL) were the most frequently mutated genes in the typical RP group. The only variant found in
CERKL was p.Arg257Stop, the most frequent mutation.
Conclusions: The genotyping microarray combined with segregation and sequence analysis allowed us to identify the
causative mutations in 11% of the families. Due to the low number of characterized families, this approach should be used
in tandem with other techniques.
Retinitis pigmentosa (RP, OMIM 268000) is an inherited
retinal dystrophy caused by a progressive loss of
photoreceptors. Typically, the first symptom of the disease is
night blindness, which is followed by a loss of peripheral
vision and, in most cases, cone degeneration in the late stage.
Its prevalence is approximately 1/4000 worldwide [1]. RP
may be transmitted in all inheritance patterns. In addition,
sporadic cases (sRP) have been described, representing 40%–
50% of non-syndromic RP cases [1]. To date, 49 genes have
been associated with RP, 32 of which are associated with
autosomal recessive retinitis pigmentosa (see arRP at
RetNet). However, only a little more than 50% of RP cases
can be explained by mutations in these genes [2]. Due to
arRP’s phenotypic and genetic heterogeneity, its molecular
diagnosis is highly complex and time-consuming.
Currently, different genotyping techniques, such as
single-strand conformation analysis [3], denaturing high-
performance liquid chromatography (HPLC) [4], arrayed
primer extension (APEX) analysis [5], and resequencing
microarrays [6], are employed for the detection of mutations
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associated with disorders showing high genetic and allelic
heterogeneity.
Several APEX arrays (Asper Biotech Ltd.; Tartu,
Estonia) have been designed for syndromic and non-
syndromic retinal dystrophies (e.g., Leber congenital
amaurosis, Stargardt disease, Usher syndrome, Bardet-Biedl
syndrome, and autosomal recessive and autosomal dominant
retinitis pigmentosa) to identify the genetic cause of the
disease.
The aim of this work was to identify the causative
mutations in a panel of Spanish subjects affected by autosomal
recessive RP (arRP) or sporadic juvenile RP and typical RP.
A complete and efficient characterization of these patients
would allow each patient to receive a more accurate prognosis
and affected families to receive appropriate genetic
counseling. Additionally, these individuals might benefit
from upcoming therapeutic methods.
We studied a cohort of 272 unrelated Spanish families
affected by autosomal recessive or sporadic juvenile RP, and
typical RP. All cases were tested using the arRP-specific
APEX genotyping microarray, followed by haplotype and
sequence analysis.
METHODS
Patients: A total of 272 unrelated Spanish families affected
by autosomal recessive and sporadic non-syndromic retinal
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dystrophy were studied. Informed consent was obtained from
all individuals recruited in accordance to the tenets of the
Declaration of Helsinki (Seoul, 2008). Two different groups
of patients—86 families with juvenile RP and 186 families
with typical RP (onset after the age of 10)—were formed and
studied independently, according to their clinical ophthalmic
diagnosis. Juvenile RP was the classification for patients who
complained of night blindness and visual field loss before the
age of 10 years. These families were also classified based on
the inheritance pattern (according to the modified criteria
published by Ayuso et al. [7], which considers sRP plus
consanguinity to be arRP: 107 families with arRP and 165
families with sRP.
In addition, 50 randomly selected DNA samples (100
chromosomes each) were taken from a healthy Spanish
control population and analyzed to establish the prevalence of
the new mutations identified in this study.
Mutational screening was performed, of one affected
member of each family, using a genotyping microarray based
on APEX technology. An APEX reaction is a genotyping
method based on a single base extension, in which hundreds
to thousands of variations in the genome are simultaneously
analyzed in a single multiplexed reaction. This approach
ensures highly specific discrimination without allele-specific
hybridization, because the primer to be extended anneals just
adjacent to the DNA base that needs to be identified. The
complete description of this methodology can be found at the
AsperBio website, and has been previously published
elsewhere [8]. The chip included all known mutations from
the coding region and adjacent intronic sequences of arRP
genes. At the start of this study, in 2006, the chip included a
total of 501 variants in 16 genes: Ceramide Kinase-Like
(CERKL), Rod cGMP-gated Channel Alpha Subunit
(CNGA1), Rod cGMP-gated Channel Beta Subunit
(CNGB1), c-Mer Proto-oncogene Tyrosine Kinase
(MERKT), cGMP Phosphodiesterase Alpha Subunit
(PDE6A), Rod cGMP Phosphodiesterase Beta Subunit
(PDE6B), Nuclear Receptor Transcription Factors (PNR),
Retinol Dehydrogenase 12 (RDH12), RPE-retinal G protein-
coupled Receptor (RGR), Retinaldehyde-Binding Protein 1
(RLBP1), Arrestin (s-antigen) (SAG), Tubby Like Protein 1
(TULP1), Crumbs Homolog 1 (CRB1), Retinal Pigment
Epithelium-specific Protein 65 kDa (RPE65), Usher
Syndrome 2A (USH2A), and Clarin 1 (USH3A).
All detected variants were confirmed by sequence
analysis. The sequence reaction was performed with a Big-
dye DNA Sequencing Kit (version 3.1; Applied Biosystems;
Foster City, CA). Sequence products were resolved in an
ABIPrism 3130 (Applied Biosystems).
Haplotype analysis studies were performed using
microsatellite markers, located within a determined interval
of the candidate gene, in those arRP families in which the
microarray detected one mutated allele. The markers were
chosen from the literature: CNGA1 from Zhang et al. [9] and
Kondo et al. [10], SAG, and USH2A from Kondo et al. [10],
CRB1 from Vallespín et al. [11], and PDE6A from Chavanás
et al. [12]. Upon detection of cosegregation in the family, we
performed bidirectional sequence analysis of the exons and
flanking intronic regions to identify the second mutated allele.
To determine the parental origin in the cases in which the
microarray detected two mutated alleles, cosegregation
analysis of the variants was performed by sequence analysis.
Novel sequence variants found were tested for their
presence in healthy control individuals by restriction fragment
length polymorphism analysis of BanI for the RDH12 c.
278T>C (p.Leu93Pro) gene variant, and by sequence analysis
for the RPE65 c.457A>G (p.Thr153Ala), USH2A c.3713C>G
(p.Thr1238Arg) and for the previously described variant: c.
12575G>A (p.Arg4192His).
Sorting intolerant from tolerant (SIFT) analysis was used
to predict the potential impact of the variants found in this
study. A SIFT score below 0.05 is predicted to be pathogenic,
while SIFT scores above 0.05 are considered tolerated.
RESULTS
Genotyping microarray analysis of juvenile RP versus typical
RP: The genotyping microarray was used for diagnosis.
Accordingly, polymorphisms were excluded before the
analysis. At least one mutation was found in 12 out of 86
(14%) families with juvenile RP and in 30 out of 186 (16%)
typical RP families studied. Of all RP alleles studied, 18 out
of 172 (10.5%) juvenile RP alleles and 46 out of 372 (12%)
typical RP alleles were identified as sequence variants.
The different variants detected with the genotyping
microarray and confirmed by sequence analysis in both
groups of patients are shown in Table 1 and Table 2. Two false
positives were detected in the juvenile RP group (RP-0337
and RP-1015; data not shown).
Segregation analysis of the families in which one variant was
found by arrayed primer extension analysis: Figure 1 shows
the results of the cosegregation analysis by microsatellite
markers in those arRP families in which the microarray
detected one mutated allele and other family members were
available. In the RP-1147, RP-0561, RP-0341, RP-0467,
RP-1016, and RP-1071 families, the studied gene variants
cosegregated with the disease, while those for RP-1292 did
not co-segregate. For RP-0235, the segregation analysis for
PDE6A showed a recombination between the D5S413 and
D5S2013 markers. For RP-0159, the p.Arg32Stop mutation
in CNGA1 is not the causative mutation of the disease in this
family since this mutation does not segregate with the disease
(data not shown). Figure 2A shows the results of the
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Procedures: DNA was extracted from peripheral blood
leukocytes collected in EDTA tubes using an automated DNA
extractor (BioRobot EZ1; Qiagen; Hilden, Germany).
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segregation analysis of those families with two mutations
identified by the microarray when other family members were
available.
Sequence analysis: For the families with one mutated allele,
one patient from each arRP family was sequenced for the gene
(CNGA1, CRB1, PDE6A, or USH2A) that cosegregated with
the disease. In the sporadic cases, the individuals who
Figure 1. Haplotype analysis of the
chromosome segments encompassing
arRP genes in those arRP families (A-
H)  in  which  the  microarray  detected
one  mutated  allele. For  the RP-1292
(E)  the  haplotype analysis shows the
studied gene does not co-segregate with
the disease. ►Where the gene is located.
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presented one mutated allele were also subjected to sequence
analysis of the gene. The index case of the RP-0134 family
could not be studied due to poor sample quality.
Using sequence analysis, we identified four novel and
four previously described variants (Table 1 and Table 2). All
novel pathogenic missense variants and the previously
described variant p.Arg4192His in USH2A were tested in a
healthy Spanish control population. None out of 100
chromosomes tested showed these changes. SIFT analysis for
the novel substitutions predicted these changes would affect
the protein function (SIFT score<0.05), except for the
p.Thr153Ala mutation in RPE65 (the SIFT analysis predicted
this change would be tolerated). The cosegregation of the
mutations with the disease was performed when other family
members were available. Family pedigrees are shown in
Figure 2B.
Three out of four previously described variants were not
included in the microarray analysis at the time of the study:
p.Glu1330Stop in CRB1 [13], p.Cys3358Tyr, and p.
Arg4192His in USH2A [14] (detected by sequence analysis in
RP-0561, RP-0260, and RP-0653, respectively). For
RP-0341, the second mutated allele, p.Gly569Lys in
PDE6A, was found by sequence analysis. That change was
included in the genotyping microarray, so in that case, the
result was considered a false negative. For families RP-1147,
RP-1311, RP-1106, RP-1023, RP-0467, RP-1016, RP-1053,
and RP-1071, which presented one mutated allele found by
Figure 2. Family pedigrees in which the co-segregation of the detected mutations was performed. “+” wild type allele, “m, m1 and m2” mutated
alleles. A: Pedigrees of families with RP mutations. B: Pedigrees of families with RP mutations.
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the genotyping microarray, the screening of the respective
genes did not show any other pathogenic variants.
DISCUSSION
Because of the high genetic heterogeneity of arRP, to identify
the genetic cause in these patients is expensive and time-
consuming. In this study, 272 Spanish families affected by
arRP were analyzed by a genotyping microarray, followed by
sequence analysis of the candidate genes to establish a fast
and effective genetic diagnosis. With this approach, we were
able to identify two pathologic variants in 30 (11%) families
one variant in 12 (4.5%) families.
In the juvenile RP group, there was not a frequent
mutation. However, for the typical RP patients, the most
frequent mutation was p.Arg257Stop in CERKL, followed by
the p.Cys759Phe mutation in USH2A.
Among the typical RP families, USH2A was the most
frequently mutated gene, with 23 out of 372 alleles. USH2A
has been shown to be involved in Usher syndrome [15] and in
RP without hearing loss [16]. In our cohort of patients,
USH2A accounted for 7% (14 out of 186) of typical RP cases
—a frequency similar to the one found in other populations
[17]. The p.Cys759Phe variant was the second-most-frequent
mutation, accounting for 3.8% (14 out of 372 alleles) of
typical RP families; this percentage was higher than reported
elsewhere [18]. CERKL was the second most-mutated gene in
Spanish patients affected by typical RP. The p.Arg257Stop
mutation is the only one found in the Spanish arRP population
to date. In our cohort of patients, the p.Arg257Stop mutation
in the CERKL gene accounted for 4.8% (9 out of 186) of
typical RP cases. In all these cases, the mutation was found
homozygously. The percentage found in this study was higher
than the one described by us previously [19], due to the
juvenile RP families having not been included in this
percentage. In addition, despite the wide geographic
distribution of these families, a common ancestry was
described [13], as all the affected members of the seven
families studied shared the same haplotype.
Among the juvenile RP families, RDH12 was the most
frequently mutated gene, with six out twenty mutated alleles.
Mutations in RDH12 have been associated with early-onset
autosomal recessive retinitis pigmentosa [20]. In our cohort
of patients, RDH12 accounted for 3.4% (3 out of 86) of the
families. This frequency is similar to the one reported in a
previous study done on a Spanish population [21], though
higher than the frequency (2.2%) found in a population from
the United States [20]. It follows from this result that the
Spanish population affected by retinal dystrophies presents
different frequencies for some genes, compared to other
populations [11].
There were no differences when the results were
compared between arRP and sRP families. Therefore, as has
been described before [22], our results support the conclusion
that a fair majority of the sporadic cases, which accounts for
40%–50% of non-syndromic RP cases, present an autosomal
recessive inheritance.
Novel variants identified by sequencing analysis: We
identified four novel pathogenic variants in three different
genes. In the USH2A gene, we found the p.Ile4582LysfsX14
and p.Thr1238Arg mutations. In the RDH12 gene, we
identified the p.Leu93Pro variation. The predicted SIFT score
(<0.05) and the absence of these variants in healthy controls
help establish the pathogenicity of these variants. The SIFT
program predicted that the missense variant p.Thr153Ala in
RPE65 would be tolerated (SIFT score >0.05).
However, the absence of change in control population and
the cosegregation with the disease in the family argues in favor
of its pathogenicity.
After the screening of USH2A for RP-0653 the
p.Arg4192His change, a previously benign variant, was
detected. However, the absence in healthy controls and the
cosegregation of the change with the family, argue in favor of
this variant being related to the retinal dystrophy in the family.
Although it is reasonable to support this conclusion, additional
studies should be performed to elucidate the pathogenic role
of this variant.
In several families (RP-1311, RP-1147, RP-1106,
RP-1023, RP-0467, RP-1016, RP-1053, and RP-1071), the
second mutated allele could not be determined. The absence
of a second pathogenic mutation in these genes could be
explained in different ways. The pathogenic mutations could
lie in other genes that interact with CRB1, CNGA1, SAG, or
USH2A, as previously described among some families with
RP [23]. It is also possible that the second mutation could not
be detected by sequence analysis because of the limitations of
the technique; large deletions have been described in
USH2A as a cause of Usher syndrome [24]. In addition, the
undetected USH2A mutations in these cases might be located
within the promoter region, intronic sequences, and 3′ and 5′
untranslated regions (UTR). Another important consideration
is why only one variant was found in some families, including
RP-0235, RP-0159, and RP-1292. In none of these did the
detected variants found by the APEX genotyping microarray
cosegregate with the disease, despite the fact that these
changes have been described as causative mutations in
different studies. The reason is that there is a considerable
mutational load in the general population. Rivolta et al. [25],
assuming a total of 67 arRP genes making equal contributions,
estimated that 10% of healthy individuals carries an arRP
variant. Thus, some of the 12 out of 272 probands in which
one pathologic variant was found may have been chance
findings that were not related to retinal dystrophy.
The APEX technology provides a quick analysis of a
large number of mutations at the same time, and allows new
mutations to be added to the microarray analysis. However, it
has some limitations. All detected changes have to be
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confirmed by sequence analysis. The array incorporates
changes of an unknown pathologic nature. The most important
disadvantage is that this microarray only tests previously
reported mutations in known genes. Finally, this array does
not include some recently identified RP genes such as the Eyes
Shut homolog (EYS) gene, which is presumed to be a major
gene for recessive RP in the Spanish population [26].
The use of the genotyping microarray, combined with
segregation and sequencing analysis, allowed us to identify
the causative mutations in at least 11% of our cohort of
patients, lower than that described using other disease-specific
microarrays (such as the LCA [6] and Usher [11] genotyping
microarray by Asper Biotech) in the Spanish population. This
approach should be used in tandem with other approaches
such as exome sequencing and indirect methods (whole-
genome single-nucleotide polymorphism [SNP] genotyping
combined with linkage analysis and homozygosity mapping).
This strategy would allow us to identify new mutations and
loci. A complete and efficient characterization of these
patients enables them to receive appropriate genetic
counseling and to contribute to the development of gene-
based therapyfor themselves and others.
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